Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · DuoTrav

DuoTrav 40 micrograms/mL + 5 mg/mL eye drops, solution · Abschnitt 4.8 · PDF-Seite 9–10

HOS-208575 · Präparat HOS-154129

9  System organ class MedDRA preferred term Immune system disorders Systemic allergic reactions including angioedema, urticaria, localised and generalised rash, pruritus, anaphylaxis Metabolism and nutrition disorders Hypoglycaemia Psychiatric disorders Hallucinations, insomnia, nightmares, memory loss Nervous system disorders Cerebral ischaemia, increases in signs and symptoms of myasthenia gravis Eye disorders Signs and symptoms of ocular irritation (e.g. burning, stinging, itching, tearing, redness), choroidal detachment following filtration surgery (see section 4.4), decreased corneal sensitivity, diplopia Cardiac disorders Oedema, congestive heart failure, atrioventricular block, cardiac arrest Vascular disorders Raynaud’s phenomenon, cold hands and feet Gastrointestinal disorders Nausea, dyspepsia, diarrhoea, dry mouth, abdominal pain, vomiting Skin and subcutaneous tissue disorders Psoriasiform rash or exacerbation of psoriasis Musculoskeletal and connective tissue disorders Myalgia Reproductive system and breast disorders Sexual dysfunction, decreased libido General disorders and administration site Asthenia conditions

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.